Syngene International Limited
NSE: SYNGENE.NS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- National Stock Exchange of India
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Peter James Jonathan Bains
- Employees
- 6,510
- Headquarters
- Bengaluru, India
- IPO year
- 2015
- Market cap
- ₹184.0B
- Website
- https://www.syngeneintl.com
Loading SYNGENE…
Loading profile data…Frequently asked questions about SYNGENE
What does Syngene International Limited (SYNGENE.NS) do?
Syngene International Limited, a contract research and manufacturing company, provides drug discovery and development services in India, the United States, and internationally. The company provides discovery chemistry services, such as medicinal and synthetic chemistry, library and peptide synthesis, biomolecules, organic electronic materials, a...
Where does SYNGENE.NS trade?
Syngene International Limited (SYNGENE.NS) trades on the National Stock Exchange of India.
What sector is SYNGENE.NS in?
Syngene International Limited (SYNGENE.NS) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Syngene International Limited?
Peter James Jonathan Bains is the chief executive officer of Syngene International Limited (SYNGENE.NS).
Where is Syngene International Limited headquartered?
Syngene International Limited is headquartered in India.
Does SYNGENE.NS pay a dividend?
Yes — Syngene International Limited (SYNGENE.NS) paid a trailing twelve-month dividend of INR 1.25 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did SYNGENE.NS go public?
Syngene International Limited (SYNGENE.NS) completed its initial public offering in 2015.